Semnur Pharmaceuticals, Inc. reports

Company 1 identity field
Location
Palo Alto, CA
SEC filing record 1 source field
Fiscal year end
31 December
Semnur Pharmaceuticals, Inc. has filed 210 SEC EDGAR filings since 01 Mar 2022

SEC filing history

Showing 1-25 of 210 matching filings.

Per page
25
Current page
1
EFFECT File 333-290995

EFFECT filing

Filing date
18 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-41351

ARS

Filing date
30 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41351

DEF 14A

Filing date
30 Apr 2026
Reporting date
25 Jun 2026
Next action
Verify source filing
EFFECT File 333-290995

EFFECT filing

Filing date
29 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-290995

424B3

Filing date
29 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-93795

SCHEDULE 13D/A filing

Filing date
14 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
26 Sep 2025
Reporting date
22 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 Sep 2025
Reporting date
23 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
23 Sep 2025
Reporting date
22 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
23 Sep 2025
Reporting date
22 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
23 Sep 2025
Reporting date
22 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
23 Sep 2025
Reporting date
22 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
23 Sep 2025
Reporting date
22 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .